1. Home
  2. PASW vs EVAX Comparison

PASW vs EVAX Comparison

Compare PASW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASW
  • EVAX
  • Stock Information
  • Founded
  • PASW 2021
  • EVAX 2008
  • Country
  • PASW Hong Kong
  • EVAX Denmark
  • Employees
  • PASW N/A
  • EVAX N/A
  • Industry
  • PASW Apparel
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PASW Consumer Discretionary
  • EVAX Health Care
  • Exchange
  • PASW Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • PASW 15.9M
  • EVAX 17.8M
  • IPO Year
  • PASW N/A
  • EVAX 2021
  • Fundamental
  • Price
  • PASW $0.52
  • EVAX $5.33
  • Analyst Decision
  • PASW
  • EVAX Strong Buy
  • Analyst Count
  • PASW 0
  • EVAX 3
  • Target Price
  • PASW N/A
  • EVAX $12.33
  • AVG Volume (30 Days)
  • PASW 48.9K
  • EVAX 155.9K
  • Earning Date
  • PASW 01-12-2026
  • EVAX 11-06-2025
  • Dividend Yield
  • PASW N/A
  • EVAX N/A
  • EPS Growth
  • PASW N/A
  • EVAX N/A
  • EPS
  • PASW N/A
  • EVAX N/A
  • Revenue
  • PASW $8,286,193.00
  • EVAX $7,650,000.00
  • Revenue This Year
  • PASW N/A
  • EVAX $129.34
  • Revenue Next Year
  • PASW N/A
  • EVAX N/A
  • P/E Ratio
  • PASW N/A
  • EVAX N/A
  • Revenue Growth
  • PASW N/A
  • EVAX 132.17
  • 52 Week Low
  • PASW $0.51
  • EVAX $1.20
  • 52 Week High
  • PASW $5.40
  • EVAX $12.15
  • Technical
  • Relative Strength Index (RSI)
  • PASW N/A
  • EVAX 46.35
  • Support Level
  • PASW N/A
  • EVAX $4.85
  • Resistance Level
  • PASW N/A
  • EVAX $5.99
  • Average True Range (ATR)
  • PASW 0.00
  • EVAX 0.49
  • MACD
  • PASW 0.00
  • EVAX -0.12
  • Stochastic Oscillator
  • PASW 0.00
  • EVAX 27.26

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: